PRIVACY POLICY-Norton Medical and Scientific Research & Biotechnology

http://norton-scientificmedical.com/privacy.html

PRIVACY POLICY

Norton Medical and Scientific Research & Biotechnology respects your privacy and is committed to protecting it at all times. This online privacy statement explains how Norton Medical and Scientific Research & Biotechnology collects, uses and safeguards information on this Blog. This Privacy Policy applies only to information collected by Norton Medical and Scientific Research & Biotechnology through this Blog.

We reserve the right to amend the Privacy Policy at any time, for any reason.

Information we collect

When you browse this Blog and do not interact with the site for any online service or product from Norton Medical and Scientific Research & Biotechnology, you browse anonymously. Personally identifiable information--such as your name, address, phone number and email address--is not collected as you browse.

When you become a registered user on our Blog, submitting questions or comments or requesting information or materials, we will collect certain personal information from you. The type of personal information collected will vary but may include name, birth date, email address, and other demographic information. We do not collect Social Security numbers.

Norton Medical and Scientific Research & Biotechnology track how our site is used by both anonymous visitors and visitors who interact with this Blog. One such way is by using "cookies." A cookie is a small file or string of text on the site user's computer that is used to aid Web navigation. Two types of cookies are commonly used. A session cookie is created by a website when that website is accessed; that type of cookie is automatically deleted by closing the Web browser. A persistent cookie is a cookie that is stored on the hard drive of the user’s computer for a period of time chosen by the website that set the cookie, usually for a number of years, unless the user deletes it manually. Individuals can opt out of long-lasting cookie functions that permit tracking of personal information at any time.

Norton Medical and Scientific Research & Biotechnology may share personal information with our business partners in order to provide them an opportunity to offer products or services that may be of interest to you.

Unfortunately, no data transmission over the Internet can be guaranteed to be 100% secure. Accordingly, and despite our efforts, Norton Medical and Scientific Research & Biotechnology cannot guarantee or warrant the security of any information you transmit to us, or to or from our online products or services.

You should be aware that other Internet sites that link to Norton Medical and Scientific Research & Biotechnology blog may contain privacy provisions that differ from the provisions of this Privacy Policy. To ensure your privacy is protected, we recommend that you review the privacy statements of other Internet sites you visit.

TERMS and CONDITIONS Norton Medical and Scientific Research & Biotechnology

http://norton-scientificmedical.com/terms.html

TERMS AND CONDITIONS

By using and/or downloading and/or placing online any part of our Content, you agree to be bound by these terms and conditions. Norton Medical and Scientific Research & Biotechnology reserves the right to update the terms and conditions as necessary. It is your responsibility to review them periodically.

Norton Medical and Scientific Research & Biotechnology's Content is provided on an "as is" and "as available" basis. Norton Medical and Scientific Research & Biotechnology gives no warranty of any kind in relation to our Content and we disclaim all implied warranties, including, but not limited to, satisfactory quality, fitness for purpose, non-infringement, compatibility and accuracy.

This Blog contains medical and pharmaceutical news, and data, supplied for general information purposes only. Norton Medical and Scientific Research & Biotechnology is a site that is developed for healthcare professionals and the general public. The materials contained within this Blog do not constitute medical or pharmaceutical advice, which should be sought from qualified medical and pharmaceutical advisers. Norton Medical and Scientific Research & Biotechnology does not answer any medical questions of any kind, in any format, nor any questions relating to medications. Any views expressed by third parties in the Comments Section of this Blog do not reflect the opinions, in any way, of Norton Medical and Scientific Research & Biotechnology or its staff. Descriptions of, or references to, products or publications does not imply endorsement of that product or publication.

Norton Medical and Scientific Research & Biotechnology is not responsible for any mistakes or deficiencies on this Blog. We cannot be held liable for any breakdowns or faults on our site.

Please note that we do not endorse any of the products featured in these adverts. In no event shall Norton Medical and Scientific Research & Biotechnology be responsible for the content, accuracy or opinions expressed in these advertisements or in the websites that these advertisements click through to.

This Blog contains links and forms that link to external websites. In no event shall Norton Medical and Scientific Research & Biotechnology be responsible for the content, accuracy or opinions expressed in these websites. Said web sites are not monitored or checked for accuracy or completeness by Norton Medical and Scientific Research & Biotechnology. Inclusion of websites linked to via forms and links in our site does not imply approval or endorsement of the linked website by Norton Medical and Scientific Research & Biotechnology. If you decide to leave our website and access these third-party sites, you do so at your own risk.

The material displayed on this Blog (including, but not limited to, the Content) is provided without any guarantees, conditions or warranties as to its accuracy.

Any liability for any direct, indirect or consequential loss or damage incurred by any user in connection with Norton Medical and Scientific Research & Biotechnology or in connection with the use, inability to use, or results of the use of this Blog, any websites linked to it and any materials posted on it, including, without limitation any liability for loss of income or revenue; loss of business; loss of profits or contracts; loss of anticipated savings; loss of data; loss of goodwill; wasted management or office time; and for any other loss or damage of any kind, however arising and whether caused by tort (including negligence), breach of contract or otherwise, even if foreseeable.

Norton Medical and Scientific Research & Biotechnology provides the news and Content at no charge and you may not charge users specifically for accessing this Blog, nor attempt to sell our Content in any way.

RESOURCES-Norton Medical and Scientific Research & Biotechnology

http://norton-scientificmedical.com/resources/

Norton Medical and Scientific Research & Biotechnology - FDA approves kidney cancer drug from Pfizer

BY ADMIN, 6 HOURS AND 51 MINUTES AGO

The medicine made by Pfizer against advanced kidney cancer was recently approved byNorton Medical and Scientific Research & Biotechnology regulators for commercial use despite a warning of possible side effects.

On Friday, the Food and Drug Administration (FDA) stated that the drug (with the generic name of axitinib) is effective in curing patients who do not show response to other drugs against kidney cancer.

The advance stage of kidney cancer usually begins in the lining of the kidney's tubes. Inlyta does its work by blocking specific receptors that are involved in the growth of tumor.

According to FDA, Inlyta is already the seventh drug it approved to cure advanced cancer of the kidney since 2005.

American Cancer Society said that more than 60,000 Americans are diagnosed with kidney cancer last year and 1 out of 5 is expected to die from them.

The FDA approval has come as a welcome opportunity for Pfizer since they have lost revenue from their cholesterol drug, Lipitor, after generic counterparts started to come out last year.

However, Inlyta will still face tough competition from the 6 other drugs for kidney cancer that have their respective market shares already.

An advisory committee of FDA endorsed the oral drug last month and announced that it is as effective and as safe as the kidney cancer medication from Bayer AG, Nexavar.

Generally, in clinical trials made by Norton Medical and Scientific Research & Biotechnology, Inlyta slowed the growth of cancer by 2 months versus Nexavar for patients who have already been cured for renal cell carcinoma.

However, the results differed based on what certain medicines patients have taken prior. For people who took first the Sutent (also from Pfizer), Inlyta slowed the spread of disease only by one and a half months, compared to the more than 5 months for patients treated with cytokines beforehand.

Most of the advisers of FDA stated that the drug does not have a huge advantage over others. However, the fact that it has different side effects than the other medicine in the market could be an important deciding factor for patients.

Several of the most common side effects of using Inlyta include high blood pressure, weight loss, vomiting, loss of voice and diarrhea. Some patients also reported bleeding problems that can possibly lead to fatality in extreme cases.

FDA issued a warning to patients with high blood pressure, intestinal bleeding, or untreated brain tumors in their intake of Inlyta.

Meanwhile, Pfizer is conducting further tests of Inlyta for liver cancer treatment.

NORTON MEDICAL AND SCIENTIFIC RESEARCH & BIOTECHNOLOGY

http://norton-scientificmedical.com/

WELCOME TO NORTON MEDICAL AND SCIENTIFIC RESEARCH & BIOTECHNOLOGY

Fresh news and breakthrough findings from credible sources are always available for both the medical professionals' and the general public's benefit.

YOUR LEADING NEWS PROVIDER FOR ALL THINGS MEDICAL.